Toronto, Canada

Zachary Steinhart

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Antlera Therapeutics Inc., Modmab Therapeutics Corporation. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zachary Steinhart. Retrieved from https://idiyas.com/inventor/zachary-steinhart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zachary Steinhart: Innovator in Protein-Binding Agents

Introduction

Zachary Steinhart is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of novel agents that target specific proteins.

Latest Patents

Zachary holds one patent for Frizzled5 protein-binding agents. This patent focuses on innovative FZD5-binding agents and outlines methods and uses for treating diseases or disorders associated with aberrant expression or activity of Frizzled proteins.

Career Highlights

Zachary is currently associated with Modmab Therapeutics Corporation, where he applies his expertise in protein interactions to advance therapeutic solutions. His work is pivotal in the ongoing research and development of treatments that address critical health issues.

Collaborations

Zachary collaborates with esteemed colleagues, including Guohua Pan and Jason Moffat, who contribute to the innovative environment at Modmab Therapeutics Corporation.

Conclusion

Zachary Steinhart's work in developing Frizzled5 protein-binding agents exemplifies the impact of innovative research in biotechnology. His contributions are essential for advancing therapeutic strategies in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…